HIMS — Hims & Hers Health Inc. stock price and chart

Share this page

HIMS

$28.07-4.46%

as of close, Oct 16, 2026

☾ AH $28.07 -4.46%

Hims & Hers Health Inc.Stock · HealthcareRussell 2000 0.2%US Stock Market 0.01%Russell 3000 0.010%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Sep 18, 2019

VolumeEEEE

20192021202320252026

10.020.030.040.050.060.00200.0M400.0M$28.07

2026-10-16

Price$28.07

MA20$30.63

MA50$27.21

Vol38.4M

What would $1,000 invested in HIMS be worth today? →

HIMS returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $28.07
YTD price return: -13.55%
YTD total return: -13.55%
Next earnings: Nov 9, 2026 · After close
Market cap: 6.5B2019-12 344.1M2026-10 6.5B+1803.2% over the window
Enterprise value: 6.1B
Shares outstanding: 233.3M2019-12 34.8M2026-06 233.3M+571.2% over the window
52W low: $13.74
52W high: $63.63
From 52W high: -55.89%
From 52W low: +104.29%
52W range: 29%

Volume

Rel volume: 1.09×
30D volume: 10.1M
30D $ vol: 291.4M

Fundamentals

Sales (ttm): 2.6B2019-12 82.6M2026-06 2.6B+3022.8% over the window
Sales/share: $11.052019-12 $2.382026-06 $11.05+365.2% over the window
EPS (ttm): -$0.582019-12 -$2.072026-06 -$0.58-71.9% over the window
FCF (ttm): 61.5M2019-12 -75.2M2026-06 61.5M-181.9% over the window
FCF/share: $0.262019-12 -$2.162026-06 $0.26-112.2% over the window
Book value/share: $1.392019-09 $0.142026-06 $1.39+865.6% over the window
Net margin: -5.51%2019-12 -87.3%2026-06 -5.5%-93.7% over the window
ROE: -43.83%2021-03 -21.7%2026-06 -43.8%+101.9% over the window
ROA: -3.91%2019-12 -35.2%2026-06 -3.9%-88.9% over the window
Current ratio: 0.932019-09 1.892026-06 0.93-50.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +28.06%2025-06-30 → 2026-06-302B → 2.6B (+28.0% total)+53.64%2023-06-30 → 2026-06-30710.7M → 2.6B (+262.7% total)+67.47%2021-06-30 → 2026-06-30195.8M → 2.6B (+1216.7% total)n/a
FCF: -48.48%2025-06-30 → 2026-06-30119.4M → 61.5M (-48.5% total)n/an/an/a
Shares: -9.14%2025-06-30 → 2026-06-30256.8M → 233.3M (-9.1% total)+3.83%2023-06-30 → 2026-06-30208.4M → 233.3M (+11.9% total)+3.98%2021-06-30 → 2026-06-30191.9M → 233.3M (+21.6% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +40.95%2025-06-30 → 2026-06-30$7.84 → $11.05 (+40.9% total)+47.97%2023-06-30 → 2026-06-30$3.41 → $11.05 (+224.0% total)+61.05%2021-06-30 → 2026-06-30$1.02 → $11.05 (+983.1% total)n/a
FCF/share: -43.30%2025-06-30 → 2026-06-30$0.47 → $0.26 (-43.3% total)n/an/an/a
Book value/share: -36.63%2025-06-30 → 2026-06-30$2.19 → $1.39 (-36.6% total)-3.29%2023-06-30 → 2026-06-30$1.54 → $1.39 (-9.6% total)-1.88%2021-06-30 → 2026-06-30$1.53 → $1.39 (-9.0% total)n/a
Price: -52.57%2025-10-16 → 2026-10-16$59.15 → $28.07 (-52.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+64.71%2023-10-16 → 2026-10-16$6.28 → $28.07 (+347.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+27.40%2021-10-15 → 2026-10-16$8.36 → $28.07 (+235.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: -52.57%2025-10-16 → 2026-10-16$59.15 → $28.07 (-52.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+64.71%2023-10-16 → 2026-10-16$6.28 → $28.07 (+347.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+27.40%2021-10-15 → 2026-10-16$8.36 → $28.07 (+235.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -48.2×2019-12 -4.782026-10 -46.11+865.7% over the window
Fwd P/E: 38.1×
P/S (ttm)Market cap ÷ TTM revenue.: 2.5×2019-12 4.172026-10 2.54-39.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 20.2×2019-12 -2.462026-10 20.21-921.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 106.4×2019-12 -4.582026-10 106.40-2424.5% over the window
EV/Sales (ttm): 2.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 0.94%2019-12 -21.8%2026-06 0.8%-103.5% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($90M) ÷ today's market cap ($6.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.37%2019-12 0.0%2026-06 1.1%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $90M + TTM dividends $0) ÷ today's market cap ($6.5B). Same caveat as the cash buyback yield.: 1.37%2019-12 0.0%2026-06 1.1%

Vs own 10Y history

P/S: 16th
P/B: 86th

Bar = where today’s multiple sits in HIMS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-4.46%

-9.22%

+0.25%

-16.66%

YTD

-13.55%

-52.54%

+235.77%

Financial statements

Open full HIMS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

HIMS — Hims & Hers Health Inc. price, chart and key statistics